SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads

被引：6
|
作者：
Ghosh, Arun K. [1 ,2 ]
Shahabi, Dana [1 ,2 ]
Imhoff, Mackenzie E. C. [3 ]
Kovela, Satish [1 ,2 ]
Sharma, Ashish [1 ,2 ]
Hattori, Shin-ichiro [4 ]
Higashi-Kuwata, Nobuyo [4 ]
Mitsuya, Hiroaki [4 ,5 ,6 ]
Mesecar, Andrew D. [7 ]
机构：
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA
[3] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA
[4] Natl Ctr Global Hlth & Med, Dept Refractory Viral Dis, Shinjuku Ku, Tokyo 1628655, Japan
[5] Kumamoto Univ Hosp, Dept Clin Sci, Kumamoto 8608556, Japan
[6] Natl Canc Inst, HIV & AIDS Malignancy Branch, Expt Retrovirol Sect, Bethesda, MD 20817 USA
[7] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2023年 / 96卷
关键词：
Antiviral; Covid-19; Inhibitor; SARS-CoV-2; protease; Synthesis;
D O I：
10.1016/j.bmcl.2023.129489
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
We report here the synthesis and biological evaluation of a series of small molecule SARS-CoV-2 PLpro inhibitors. We compared the activity of selected compounds in both SARS-CoV-1 and SARS-CoV-2 PLpro inhibitory and antiviral assays. We have synthesized and evaluated several new structural variants of previous leads against SARS-CoV-2 PLpro. The replacement of the carboxamide functionality with sulfonamide derivatives resulted in PLpro inhibitors with potent PLpro inhibitory and antiviral activity in VeroE6 cells similar to GRL0617. To obtain molecular insight, we created an optimized model of a potent sulfonamide derivative in the SARS-CoV-2 PLpro active site.
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors
    Li, Daoqun
    Luan, Junwen
    Zhang, Leiliang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 72 - 79
  • [22] Development of a Fluorescence Polarization Assay for the SARS-CoV-2 Papain-like Protease
    Li, Kan
    Jadhav, Prakash
    Wen, Yu
    Tan, Haozhou
    Wang, Jun
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2025, 8 (03) : 774 - 784
  • [23] Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor
    Ma, Chunlong
    Hu, Yanmei
    Wang, Yuyin
    Choza, Juliana
    Wang, Jun
    ACS INFECTIOUS DISEASES, 2022, 8 (05): : 1022 - 1030
  • [24] Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery
    Sk. Abdul Amin
    Kalyan Ghosh
    Samayaditya Singh
    Insaf Ahmed Qureshi
    Tarun Jha
    Shovanlal Gayen
    Molecular Diversity, 2022, 26 : 215 - 228
  • [25] Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery
    Amin, Sk. Abdul
    Ghosh, Kalyan
    Singh, Samayaditya
    Qureshi, Insaf Ahmed
    Jha, Tarun
    Gayen, Shovanlal
    MOLECULAR DIVERSITY, 2022, 26 (01) : 215 - 228
  • [26] Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV-2 papain-like protease
    Zou, Zhihui
    Shan, Huizhuang
    Sun, Demeng
    Xia, Li
    Shi, Yulong
    Wan, Jiahui
    Zhou, Aiwu
    Wu, Yunzhao
    Xu, Hanzhang
    Lei, Hu
    Xu, Zhijian
    Wu, Yingli
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (08) : 1133 - 1139
  • [27] Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay
    Pitsillou, Eleni
    Liang, Julia
    Ververis, Katherine
    Lim, Kah Wai
    Hung, Andrew
    Karagiannis, Tom C.
    FRONTIERS IN CHEMISTRY, 2020, 8
  • [28] Structure-based design of SARS-CoV-2 papain-like protease inhibitors
    Jadhav, Prakash
    Huang, Bo
    Osipiuk, Jerzy
    Zhang, Xiaoming
    Tan, Haozhou
    Tesar, Christine
    Endres, Michael
    Jedrzejczak, Robert
    Tan, Bin
    Deng, Xufang
    Joachimiak, Andrzej
    Cai, Jianfeng
    Wang, Jun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 264
  • [29] Natural biflavones are potent inhibitors against SARS-CoV-2 papain-like protease
    Li, Lingyu
    Ma, Liyan
    Hu, Yue
    Li, Xiaoxue
    Yu, Meng
    Shang, Hai
    Zou, Zhongmei
    PHYTOCHEMISTRY, 2022, 193
  • [30] Molecular Dynamics and Inhibition of MERS CoV Papain-like Protease by Small Molecule Imidazole and Aminopurine Derivatives
    Kandeel, Mahmoud
    Altaher, Abdallah
    Alnazawi, Mohamed
    LETTERS IN DRUG DESIGN & DISCOVERY, 2019, 16 (05) : 584 - 591
12345